GOLDENWELL BIOTECH, INC. (GWLL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 20 40 60 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 55 Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 5 10 15 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 12 Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-45K -30K -15K 0 15K 30K 45K Q3 '24: -21K Q4 '24: -25.4K Q1 '25: -36.4K Q2 '25: -28.2K Q3 '25: -25.8K Q4 '25: -22.9K Q1 '26: -31.3K Q2 '26: -34.8K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-210K -140K -70K 0 70K 140K 210K Q3 '24: -23.1K Q4 '24: -27.5K Q1 '25: -38.5K Q2 '25: -30.3K Q3 '25: -27.9K Q4 '25: -199.7K Q1 '26: -17.6K Q2 '26: -36.9K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 15 30 45 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 43 Q1 '26: 0 Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-50K -25K 0 25K 50K 75K Q3 '24: -21K Q4 '24: -25.4K Q1 '25: -32.3K Q2 '25: 59.4K Q3 '25: -30.9K Q4 '25: -18.8K Q1 '26: -13.4K Q2 '26: -47.3K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 35M 70M 105M Q3 '24: 96.4M Q4 '24: 99M Q1 '25: 99M Q2 '25: 99M Q3 '25: 96.4M Q4 '25: 99M Q1 '26: 99M Q2 '26: 99M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '21 Q4 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.